SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000861177-24-000004
Filing Date
2024-02-13
Accepted
2024-02-13 13:34:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 EXIT FILING PRELUDE_4Q2023_Exit.txt SC 13G/A 9167
  Complete submission text file 0000861177-24-000004.txt   11082
Mailing Address ONE NORTH WACKER DRIVE CHICAGO IL 60606
Business Address ONE NORTH WACKER DRIVE CHICAGO IL 60606 60606
UBS ASSET MANAGEMENT AMERICAS INC (Filed by) CIK: 0000861177 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805
Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280
Prelude Therapeutics Inc (Subject) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91717 | Film No.: 24624348
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)